dr. tewari on the trial design with cemiplimab in cervical cancer
Published 6 years ago • 159 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:40
dr. tewari on trial with cemiplimab in recurrent or metastatic cervical cancer
-
1:45
dr. tewari on the evolution of treatment in cervical cancer
-
0:42
combining cemiplimab and isa101b for the treatment of recurrent/metastatic hpv16 cervical cancer
-
0:55
dr. tewari on the promise of immunotherapy in cervical cancer
-
1:36
dr. tewari on immunotherapeutic strategies in cervical cancer
-
1:14
dr. tewari on the next steps for bevacizumab in recurrent cervical cancer
-
1:06
dr. krishnansu tewari on bevacizumab in advanced cervical cancer
-
1:16
dr. rischin discusses the future of cemiplimab in cervical cancer
-
9:32
medullary thyroid cancer treatment overview.
-
11:47
small thyroid cancers, thyroid hormones, and more.
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
2:07
dr. tewari on the impact of ctcs on survival among patients with advanced cervical cancer
-
0:21
integrating cemiplimab isa101b into the treatment paradigm for recurrent hpv16 cervical cancer
-
8:52
frontline therapies for metastatic cervical cancer
-
0:42
dr. rischin discusses role of cemiplimab in cervical cancer
-
1:13
dr. rischin discusses cemiplimab in cervical cancer
-
1:45
dr. coleman on the clinical implications of the innovatv 204 trial in cervical cancer
-
2:26
dr. krishnansu tewari on a phase iii trial exploring bevacizumab in recurrent cervical cancer
-
1:36
dr. ferguson on the impact of the lacc trial data on cervical cancer surgery
-
0:54
dr. randall on emerging treatment strategies in cervical cancer
-
0:52
immunotherapy enters the treatment landscape for cervical cancer
-
1:45
dr. hong on the safety profile of tisatumab vedotin in cervical cancer